Literature DB >> 15967669

Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.

Ruben Smith1, Asa Petersén, Gillian P Bates, Patrik Brundin, Jia-Yi Li.   

Abstract

Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by progressive psychiatric, cognitive, and motor disturbances. We studied the expression of synaptic vesicle proteins in the R6/1 transgenic mouse model of HD. We observed that the levels of rabphilin 3A, a protein involved in exocytosis, is substantially decreased in synapses of most brain regions in R6/1 mice. The appearance of the reduction coincides with the onset of motor deficits and behavioral disturbances. Double immunohistochemistry did not show colocalization between rabphilin 3A and huntingtin aggregates in the HD mice. Using in situ hybridization, we demonstrated that rabphilin 3A mRNA expression was substantially reduced in the R6/1 mouse cortex compared to wild-type mice. Our results indicate that a decrease in mRNA levels underlie the depletion of protein levels of rabphilin 3A, and we suggest that this reduction may be involved in causing impaired synaptic transmission in R6/1 mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967669     DOI: 10.1016/j.nbd.2005.05.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

1.  Effects of carbonic anhydrase VIII deficiency on cerebellar gene expression profiles in the wdl mouse.

Authors:  Jian Yan; Yan Jiao; Feng Jiao; John Stuart; Leah Rae Donahue; Wesley G Beamer; Xinmin Li; Bruce A Roe; Mark S LeDoux; Weikuan Gu
Journal:  Neurosci Lett       Date:  2006-12-15       Impact factor: 3.046

2.  Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.

Authors:  Reena Prity Murmu; Wen Li; Anthony Holtmaat; Jia-Yi Li
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

3.  Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium.

Authors:  Benjamin Ray Miller; Ilya Bezprozvanny
Journal:  Future Neurol       Date:  2010-09

Review 4.  The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.

Authors:  Jia Yi Li; Natalija Popovic; Patrik Brundin
Journal:  NeuroRx       Date:  2005-07

Review 5.  The corticostriatal pathway in Huntington's disease.

Authors:  Carlos Cepeda; Nanping Wu; Véronique M André; Damian M Cummings; Michael S Levine
Journal:  Prog Neurobiol       Date:  2006-12-13       Impact factor: 11.685

6.  Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.

Authors:  Daniele Bertoglio; Jeroen Verhaeghe; Leonie Wyffels; Alan Miranda; Sigrid Stroobants; Ladislav Mrzljak; Celia Dominguez; Mette Skinbjerg; Jonathan Bard; Longbin Liu; Ignacio Munoz-Sanjuan; Steven Staelens
Journal:  J Nucl Med       Date:  2021-09-16       Impact factor: 11.082

7.  Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.

Authors:  Chee Yeun Chung; James B Koprich; Hasan Siddiqi; Ole Isacson
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 8.  Transcriptional signatures in Huntington's disease.

Authors:  Jang-Ho J Cha
Journal:  Prog Neurobiol       Date:  2007-04-01       Impact factor: 11.685

Review 9.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

10.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.